Literature DB >> 12143336

Complications associated with genetic background effects in models of experimental epilepsy.

P Elyse Schauwecker1.   

Abstract

To elucidate the genetic influences contributing to susceptibility to seizure disorders, researchers have long used selected lines and inbred strains of rodents. In recent years, the use of genetically altered mice as models of complex human disease has revolutionized biomedical research into the genetics of disease pathogenesis and potential therapeutic interventions. In particular, the study of transgenic and gene-deleted (knockout) mice can provide important insights into the in vivo function and interaction of specific gene products. While a variety of inbred mouse mutations have been used to directly evaluate the genetic basis of seizure disorders, data obtained from such genetically altered mice must be interpreted carefully. An increasing number of scientific articles have reported that the phenotype of a given single gene mutation in mice can be modulated by the genetic background of the inbred strain in which the mutation is maintained. This effect is attributable to so-called modifier genes, which act in combination with the causative gene. In this review, the author points out the importance of considering the genetic background of the strain used to create these animal models, the potential problems with interpretation of phenotype, and solutions to selecting an appropriate mouse model of experimental epilepsy. Despite these potential limitations, knockout mice provide a powerful tool for understanding the genetic and neurobiological mechanisms contributing to experimental epilepsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12143336     DOI: 10.1016/s0079-6123(02)35014-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  27 in total

1.  Telomerase immortalization of principal cells from mouse collecting duct.

Authors:  Stacy L Steele; Yongren Wu; Robert J Kolb; Monika Gooz; Courtney J Haycraft; Kent T Keyser; Lisa Guay-Woodford; Hai Yao; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

Review 2.  Using mice to model cognitive deficits in neurologic disorders: narrowing in on Rett syndrome.

Authors:  Joanne Berger-Sweeney
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

Review 3.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  The relevance of individual genetic background and its role in animal models of epilepsy.

Authors:  P Elyse Schauwecker
Journal:  Epilepsy Res       Date:  2011-10-15       Impact factor: 3.045

5.  Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro.

Authors:  Kara Buehrer Kile; Nan Tian; Dominique M Durand
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

6.  Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain.

Authors:  P Elyse Schauwecker
Journal:  Exp Neurol       Date:  2010-03-29       Impact factor: 5.330

7.  Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness.

Authors:  Stephen H Tsang; Michael L Woodruff; Lin Jun; Vinit Mahajan; Clyde K Yamashita; Robert Pedersen; Chyuan-Sheng Lin; Stephen P Goff; Thomas Rosenberg; Michael Larsen; Debora B Farber; Steven Nusinowitz
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

8.  Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Authors:  Meredith C Lane; Joshua G Jackson; Elizabeth N Krizman; Jeffery D Rothstein; Brenda E Porter; Michael B Robinson
Journal:  Neurochem Int       Date:  2013-12-12       Impact factor: 3.921

9.  Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion.

Authors:  P Elyse Schauwecker; Ruth I Wood; Ariana Lorenzana
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

10.  Chronic brain injury and behavioral impairments in a mouse model of term neonatal strokes.

Authors:  Shilpa D Kadam; Justin D Mulholland; Dani R Smith; Michael V Johnston; Anne M Comi
Journal:  Behav Brain Res       Date:  2008-08-12       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.